121 related articles for article (PubMed ID: 11975633)
1. A novel short convergent entry into himbacine derivatives.
Van Cauwenberge G; Gao LJ; Van Haver D; Milanesio M; Viterbo D; De Clercq PJ
Org Lett; 2002 May; 4(9):1579-82. PubMed ID: 11975633
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis, and structure-activity relationship studies of himbacine derived muscarinic receptor antagonists.
Doller D; Chackalamannil S; Czarniecki M; McQuade R; Ruperto V
Bioorg Med Chem Lett; 1999 Mar; 9(6):901-6. PubMed ID: 10206558
[TBL] [Abstract][Full Text] [Related]
3. Synthetic studies on himbacine, a potent antagonist of the muscarinic M2 subtype receptor. Part 2: synthesis and muscarinic M2 subtype antagonistic activity of the novel himbacine congeners modified at the C-3 position of lactone moiety.
Takadoi M; Yamaguchi K; Terashima S
Bioorg Med Chem; 2003 Apr; 11(7):1169-86. PubMed ID: 12628644
[TBL] [Abstract][Full Text] [Related]
4. IMDA-radical cyclization approach to (+)-himbacine.
Wong LS; Sherburn MS
Org Lett; 2003 Oct; 5(20):3603-6. PubMed ID: 14507183
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and affinity studies of himbacine derived muscarinic receptor antagonists.
Gao LJ; Waelbroeck M; Hofman S; Van Haver D; Milanesio M; Viterbo D; De Clercq PJ
Bioorg Med Chem Lett; 2002 Aug; 12(15):1909-12. PubMed ID: 12113806
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and muscarinic M2 subtype antagonistic activity of unnatural ent-himbacine and an enantiomeric pair of (2'S,6'R)-diepihimbacine.
Takadoi M; Terashima S
Bioorg Med Chem Lett; 2002 Oct; 12(20):2871-3. PubMed ID: 12270166
[TBL] [Abstract][Full Text] [Related]
7. The bromopentadienyl acrylate approach to himbacine.
Wong LS; Sharp LA; Xavier NM; Turner P; Sherburn MS
Org Lett; 2002 May; 4(11):1955-7. PubMed ID: 12027656
[TBL] [Abstract][Full Text] [Related]
8. Himbacine analogs as muscarinic receptor antagonists--effects of tether and heterocyclic variations.
Chackalamannil S; Doller D; McQuade R; Ruperto V
Bioorg Med Chem Lett; 2004 Aug; 14(15):3967-70. PubMed ID: 15225708
[TBL] [Abstract][Full Text] [Related]
9. Diphenyl sulfoxides as selective antagonists of the muscarinic M2 receptor.
Kozlowski JA; Lowe DB; Guzik HS; Zhou G; Ruperto VB; Duffy RA; McQuade R; Crosby G; Taylor LA; Billard W; Binch H; Lachowicz JE
Bioorg Med Chem Lett; 2000 Oct; 10(20):2255-7. PubMed ID: 11055332
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and muscarinic M(2) subtype antagonistic activity of enantiomeric pairs of 3-demethylhimbacine (3-norhimbacine) and its C(4)-epimer.
Takadoi M; Yamaguchi K; Terashima S
Bioorg Med Chem Lett; 2002 Nov; 12(22):3271-3. PubMed ID: 12392730
[TBL] [Abstract][Full Text] [Related]
11. Biomimetic total synthesis of (+)-himbacine.
Tchabanenko K; Adlington RM; Cowley AR; Baldwin JE
Org Lett; 2005 Feb; 7(4):585-8. PubMed ID: 15704900
[TBL] [Abstract][Full Text] [Related]
12. An approach to the skeleton of the securinega alkaloids. The total synthesis of (+/-)-securinine.
Liras S; Davoren JE; Bordner J
Org Lett; 2001 Mar; 3(5):703-6. PubMed ID: 11259041
[TBL] [Abstract][Full Text] [Related]
13. Total synthesis of (+)-galbulimima alkaloid 13 and (+)-himgaline.
Evans DA; Adams DJ
J Am Chem Soc; 2007 Feb; 129(5):1048-9. PubMed ID: 17263383
[No Abstract] [Full Text] [Related]
14. Structure-activity relationships of some Galbulimima alkaloids related to himbacine.
Darroch SA; Taylor WC; Choo LK; Mitchelson F
Eur J Pharmacol; 1990 Jun; 182(1):131-6. PubMed ID: 2401311
[TBL] [Abstract][Full Text] [Related]
15. The cardio-selectivity of himbacine: a muscarine receptor antagonist.
Anwar-ul S; Gilani H; Cobbin LB
Naunyn Schmiedebergs Arch Pharmacol; 1986 Jan; 332(1):16-20. PubMed ID: 3951563
[TBL] [Abstract][Full Text] [Related]
16. Structural basis of the subtype selectivity of muscarinic antagonists: a study with chimeric m2/m5 muscarinic receptors.
Wess J; Gdula D; Brann MR
Mol Pharmacol; 1992 Feb; 41(2):369-74. PubMed ID: 1538713
[TBL] [Abstract][Full Text] [Related]
17. Binding and functional selectivity of himbacine for cloned and neuronal muscarinic receptors.
Miller JH; Aagaard PJ; Gibson VA; McKinney M
J Pharmacol Exp Ther; 1992 Nov; 263(2):663-7. PubMed ID: 1331410
[TBL] [Abstract][Full Text] [Related]
18. Himbacine derived thrombin receptor (PAR-1) antagonists: structure-activity relationship of the lactone ring.
Xia Y; Chackalamannil S; Chan TM; Czarniecki M; Doller D; Eagen K; Greenlee WJ; Tsai H; Wang Y; Ahn HS; Boykow GC; McPhail AT
Bioorg Med Chem Lett; 2006 Sep; 16(18):4969-72. PubMed ID: 16824760
[TBL] [Abstract][Full Text] [Related]
19. The interaction of methoctramine and himbacine at atrial, smooth muscle and endothelial muscarinic receptors in vitro.
Eglen RM; Montgomery WW; Dainty IA; Dubuque LK; Whiting RL
Br J Pharmacol; 1988 Dec; 95(4):1031-8. PubMed ID: 3219478
[TBL] [Abstract][Full Text] [Related]
20. Himbacine recognizes a high affinity subtype of M2 muscarinic cholinergic receptors in the rat cerebral cortex.
Wang JX; Roeske WR; Wang W; Yamamura HI
Brain Res; 1988 Apr; 446(1):155-8. PubMed ID: 3370478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
